Palladium-103 brachytherapy for prostate carcinoma
- 1 March 2000
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 46 (4), 839-850
- https://doi.org/10.1016/s0360-3016(99)00499-x
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- The effect of prognostic factors on therapeutic outcome following transperineal prostate brachytherapySeminars in Surgical Oncology, 1997
- Interstitial implantation techniques in prostate cancerJournal of Surgical Oncology, 1997
- Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinomaCancer, 1997
- Biochemical disease-free survival following 125I prostate implantationInternational Journal of Radiation Oncology*Biology*Physics, 1997
- SHOULD BRACHYTHERAPY BE CONSIDERED A THERAPEUTIC OPTION IN LOCALIZED PROSTATE CANCER?Urologic Clinics of North America, 1996
- DOES BRACHYTHERAPY HAVE A ROLE IN THE TREATMENT OF PROSTATE CANCER?Hematology/Oncology Clinics of North America, 1996
- Prostate Specific Antigen Based Disease Control Following Ultrasound Guided sup 125 Iodine Implantation for Stage T1/T2 Prostatic CarcinomaJournal of Urology, 1995
- Brachytherapy and organ preservation in the management of carcinoma of the prostateSeminars in Radiation Oncology, 1993
- Permanent interstitial implantation using palladium-103: The new york medical college preliminary experienceInternational Journal of Radiation Oncology*Biology*Physics, 1992
- 125 Iodine implantation after lymphadenectomy in early carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1986